CN Patent

CN106365966A — 一种苄基芳基醚的制备方法

Assigned to Shanghai Pharmaceuticals Holding Co Ltd · Expires 2017-02-01 · 9y expired

What this patent protects

本发明公开了一种高纯度苄基芳基醚4-(3-氟苄氧基)-苯甲醛及其衍生物的制备方法。该方法在有机碱的存在下，将苄基衍生物与对羟基苯甲醛缩合制备苄基芳基醚4-(3-氟苄氧基)-苯甲醛及其衍生物。该方法具有反应条件温和，操作简便，反应选择性好，产物纯度高，易实现工业化生产的特点。

USPTO Abstract

本发明公开了一种高纯度苄基芳基醚4-(3-氟苄氧基)-苯甲醛及其衍生物的制备方法。该方法在有机碱的存在下，将苄基衍生物与对羟基苯甲醛缩合制备苄基芳基醚4-(3-氟苄氧基)-苯甲醛及其衍生物。该方法具有反应条件温和，操作简便，反应选择性好，产物纯度高，易实现工业化生产的特点。

Drugs covered by this patent

Patent Metadata

Patent number
CN106365966A
Jurisdiction
CN
Classification
—
Expires
2017-02-01
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Pharmaceuticals Holding Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.